Clinical Trials Directory

Trials / Terminated

TerminatedNCT02695667

Quantitative Genioglossal Muscle Strength in Obstructive Sleep Apnea (OSAS)

Quantitative Genioglossal Muscle Strength in Obstructive Sleep Apnea (OSAS) Defined in the Clinical Spectrum of Subjects With Snoring Disturbance, Oral Appliance Therapy Responsive, and CPAP Responsive.

Status
Terminated
Phase
Study type
Observational
Enrollment
13 (actual)
Sponsor
University of New Mexico · Academic / Other
Sex
All
Age
20 Years – 40 Years
Healthy volunteers
Accepted

Summary

Quantitative Genioglossal muscle strength in Obstructive Sleep Apnea (OSAS) defined in the clinical spectrum of subjects with Snoring Disturbance, Oral Appliance Therapy Responsive, and CPAP Responsive

Detailed description

To describe by statistical analysis the normal distribution domain of genioglossus muscle strength in each of the four clinical stages of Sleep Apnea; and, by regression analysis, to explore the possibility of an inverse relationship between decreasing genioglossus strength and progression of the clinical stages of OSAS. 1.3. To test the hypothesis that a "subpopulation of subject" exists within the clinical spectrum of OSAS, in whom decreasing strength of the genioglossus muscle may represent a common element in spite of differing possible pathophysiologic pathways leading to Obstructive Sleep Apnea in man. 1.4. The major hypothesis of this proposal is thus that "Genioglossal Strength is inversely correlated with Obstructive Sleep Apnea Pathology."

Conditions

Timeline

Start date
2016-02-01
Primary completion
2017-03-01
Completion
2017-03-01
First posted
2016-03-01
Last updated
2024-01-08

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02695667. Inclusion in this directory is not an endorsement.